A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease. Will these tests change how cognitive decline is measured?

Mass spectrometry-based lipidomics and metabolomics generate large, complex datasets requiring effective analysis. Here, authors review key statistical and visualization methods alongside widely used R and Python tools, and provide a GitBook with step-by-step code for accessible, reproducible data analysis.

Lithium has an essential role in the brain and is deficient early in Alzheimer’s disease, which can be recapitulated in mice and treated with a novel lithium salt that restores the physiological level...

Studies in rodents and humans suggest that low levels of the metal contribute to cognitive decline.

Experiments in mouse models show that proper recovery of the intestinal microbiota following depletion, with or without faecal microbiota transplant therapy, is dependent on syntrophic interactions th...

After three postdoc positions, this researcher now sees her skills and knowledge as valuable

Nature Biotechnology - An open letter to graduate students and other procrastinators: it’s time to write

Women with polycystic ovary syndrome (PCOS) find it harder to get pregnant, have more frequent miscarriages and have a higher risk of developing endometrial cancer. Now, in a new study published in Na...

Writing in Nature Reviews Microbiology, a group of scientists updates the healthy human microbiome concept by combining independent measures of both the host and the microbial community health, and pr...

The Biomarker Laboratory at the University of Eastern Finland Brain Research Unit is launching diagnostics for a biomarker of Alzheimer’s disease, to be measured from a blood sample.